We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+8.92%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$223B
AUM Growth
+$132B
Cap. Flow
+$128B
Cap. Flow %
57.4%
Top 10 Hldgs %
41.38%
Holding
5,646
New
798
Increased
2,634
Reduced
1,094
Closed
385

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$2.5B
2
AAPL icon
Apple
AAPL
+$1.68B
3
TSLA icon
Tesla
TSLA
+$951M
4
JNJ icon
Johnson & Johnson
JNJ
+$750M
5
UNH icon
UnitedHealth
UNH
+$703M

Sector Composition

Rank Sector Weight
1 Technology 12.48%
2 Healthcare 7.36%
3 Financials 6.5%
4 Consumer Discretionary 5.35%
5 Industrials 3.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHCO
5051
DELISTED
Soho House & Co
SHCO
$4 ﹤0.01%
1
-254
-100% -$1.04K
MOTS
5052
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
0
MBOT icon
5053
Microbot Medical
MBOT
$117M
$3 ﹤0.01%
1
SOS
5054
SOS Limited
SOS
$17.3M
0
VYNT
5055
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$2 ﹤0.01%
3
CRVS icon
5056
Corvus Pharmaceuticals
CRVS
$1.11B
$1 ﹤0.01%
1
ATHX
5057
DELISTED
Athersys, Inc. Common Stock
ATHX
$1 ﹤0.01%
1
ADAP
5058
DELISTED
Adaptimmune Therapeutics
ADAP
-340,068
Closed -$366K
ADN
5059
DELISTED
Advent Technologies
ADN
-55
Closed -$5K
AENT icon
5060
Alliance Entertainment
AENT
$282M
-92,136
Closed -$917K
AFRI icon
5061
Forafric Global
AFRI
$282M
-36,641
Closed -$412K
AIRG icon
5062
Airgain
AIRG
$72.8M
-158
Closed -$1K
ALLR
5063
Allarity Therapeutics
ALLR
$19.6M
0
-$18K
AMX icon
5064
America Movil
AMX
$76B
-2
Closed
APT icon
5065
Alpha Pro Tech
APT
$50.7M
-2,044
Closed -$8K
ASYS icon
5066
Amtech Systems
ASYS
$259M
-184
Closed -$2K
AXSM icon
5067
Axsome Therapeutics
AXSM
$12.1B
-26,572
Closed -$1.19M
AYTU icon
5068
AYTU BioPharma
AYTU
$23.1M
0
BBUS icon
5069
JPMorgan BetaBuilders US Equity ETF
BBUS
$8.78B
-9,400
Closed -$605K
BETR icon
5070
Better Home & Finance Holding
BETR
$402M
-2,113
Closed -$1.04M
BKSY icon
5071
BlackSky Technology
BKSY
$919M
-544
Closed -$7K
BL icon
5072
CALL
BlackLine
BL
$1.8B
-50,000
Closed -$3M
BLTE
5073
Belite Bio
BLTE
$6.41B
-6,661
Closed -$223K
BNZI icon
5074
Banzai International
BNZI
$6.03M
-22
Closed -$2.16M
BRZE icon
5075
Braze
BRZE
$2.82B
-1,000
Closed -$35K

Similar funds

Barclays's Q4 2022 Portfolio in Review

As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Barclays deployed $128B of net new capital in Q4 2022, opening 798 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.

  • Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
  • Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
  • Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
  • Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
  • Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
  • Barclays opened 798 new positions and closed 385 in Q4 2022.
  • Barclays's portfolio value rose 144% quarter-over-quarter to $223B.

Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.